+1-947-333-4405
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Mini Review
Prognostic Factors in Onychomycosis Treatment
| Shari R Lipner* and Richard K Scher | ||
| Weill Cornell Medical College Dermatology, New York, USA | ||
| Corresponding Author : | Shari Lipner Dermatology, Weill Cornell Medical College Dermatology, Cornell Dermatology Consultant 1305 York Ave, New York, NY 10021 Tel: 646-962-3376 E-mail: shl9032@med.cornell.edu |
|
| Received November 06, 2014; Accepted January 26, 2015; Published February 05, 2015 | ||
| Citation: Lipner SR, Scher RK (2015) Prognostic Factors in Onychomycosis Treatment. J Infect Dis Ther 3:202. doi: 10.4172/2332-0877.1000202 | ||
| Copyright: © 2015 Lipner SR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | ||
Related article at Pubmed Scholar Google |
||
Abstract
Onychomycosis is a common fungal disease of the nail unit with a prevalence of 10% to 12% in the United States. Despite therapeutic innovations in the last few decades, as many as 20-25% of patients do not achieve a complete cure, and 10-53% are reported to relapse after successful treatment. Some of the factors associated with a poor response to onychomycosis have been well studied. They include patient characteristics and morbidities, nail characteristics, and the infecting organism. Therefore, the goal of therapy is to identify these specific prognostic features for each patient and devise an appropriate treatment plan that will allow for the best chance for cure. Scoring systems may be helpful for grading the severity of onychomycosis and predicting the therapeutic outcome.
